NCCS and Cancer Groups Urge National Academy of Medicine to Include Cancer Patients in Phase IB COVID-19 Vaccine Allocation
NCCS joined with a group of patient and provider advocacy groups in a letter to the National Academy of Medicine (NAM) on vaccine allocation. In the letter, the groups articulate the substantial risk that cancer patients face during the pandemic and shared data on the negative outcomes of patients with cancer and concurrent COVID-19. The […]